Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 2(63), 2019
DOI: 10.1128/aac.01777-18
Links
Tools
In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis
Journal article published in 2018 by
Renátó Kovács,
Jeanett Holzknecht,
Zoltán Hargitai,
Csaba Papp 
,
Attila Farkas,
Attila Borics,
Lilána Tóth,
Györgyi Váradi,
Gábor K. Tóth,
Ilona Kovács,
Sandrine Dubrac ,
László Majoros,
Florentine Marx,
László Galgóczy
,
Attila Farkas,
Attila Borics,
Lilána Tóth,
Györgyi Váradi,
Gábor K. Tóth,
Ilona Kovács,
Sandrine Dubrac ,
László Majoros,
Florentine Marx,
László Galgóczy
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
As a consequence of emerging numbers of vulvovaginitis cases caused by azole-resistant and biofilm-forming Candida species, fast and efficient treatment of this infection has become challenging. The problem is further exacerbated by the severe side effects of azoles as long-term-use medications in the recurrent form.